Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:28 PM
Ignite Modification Date:
2025-12-24 @ 1:28 PM
NCT ID:
NCT01031095
Eligibility Criteria:
Inclusion Criteria:
* The patients; who have planned elective PCI and have had written informed consent for participation to study.
* The native coronary artery;
* lesion with narrowing \>=70%,
* lesion without thrombus
* no left main coronary artery (LMCA) lesion
* no chronic total occlusion lesion
Exclusion Criteria:
* Patients have allergy for acetylsalicylic acid (ASA), Clopidogrel and heparin
* Patients who performed primary PCI
* Patients with acute coronary syndrome
* Patients with have a history of myocardial infarction (MI) for two weeks
* Patients who were use UFH or low molecular weight heparin (LMWH) for 24 hours
* Patients on warfarin therapy
* Patients who have bleeding diathesis, or have high risk for bleeding.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT01031095
Study Brief:
Protocol Section:
NCT01031095